Ketut Dewi Kumara Wati

Dr. Ketut Dewi Kumara Wati


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 November 2022 in Vaccines
Verified
Journal Article
Open access
PDF file
Harapan HarapanHarapan Harapan
Harapan Harapan
RFRaisha Fathima
Raisha Fathima
HKHendrix Indra Kusuma
Hendrix Indra Kusuma
SASamsul Anwar
Samsul Anwar
WNWidhy Yudistira Nalapraya
Widhy Yudistira Nalapraya
Mudatsir MudatsirMudatsir Mudatsir
Mudatsir Mudatsir
Obtaining a booster dose of coronavirus disease 2019 (COVID-19) vaccine is required to maintain the protective level of neutralizing antibodies and therefore herd immunity in the community, and the success of booster dose programs depends on public acceptance. The aim of this study was to determine the acceptance of a booster dose of COVID-19 vaccine and its drivers and barriers in Indonesia. A cross-sectional survey was conducted in the provinces of Indonesia between 1 and 15 August 2022. Individuals who completed the primary series of the COVID-19 vaccine were asked about their acceptance of a booster dose. Those who refused the booster dose were questioned about their reasons. A logistic regression was used to determine the determinants associated with rejection of a booster dose of COVID-19 vaccine. A total of 2935 respondents were included in the final analysis. With no information on the efficacy and safety of the COVID-19 vaccine, 95% of respondents agreed to receive a booster dose if it were provided for free by the government. This acceptance was reduced to only 50.3% if the vaccine had a 75% efficacy with a 20% chance of side effects. The adjusted logistic regression analysis indicated that there were eight factors associated with the rejection of the booster dose: age, marital status, religion, occupation, type of the first two vaccines received, knowledge regarding the importance of the booster dose, belief that natural immunity is sufficient to prevent COVID-19 and disbelief in the effectiveness of the booster dose. In conclusion, the hesitancy toward booster doses in Indonesia is influenced by some intrinsic factors such as lack of knowledge on the benefits of the booster dose, worries regarding the unexpected side effects and concerns about the halal status of the provided vaccines and extrinsic determinants such as the effectiveness and safety of the vaccine. These findings suggest the need for more campaigns and promotions regarding the booster dose benefits to increase its acceptance.

11 December 2022 in Infectious Disease Reports
Verified
Journal Article
Open access
PDF file
Harapan HarapanHarapan Harapan
Harapan Harapan
Malik SallamMalik Sallam
Malik Sallam
RFRaisha Fathima
Raisha Fathima
HKHendrix Indra Kusuma
Hendrix Indra Kusuma
SASamsul Anwar
Samsul Anwar
Mudatsir MudatsirMudatsir Mudatsir
Mudatsir Mudatsir
Willingness to pay (WTP) for booster doses of coronavirus disease 2019 (COVID-19) vaccines is an under studied research topic. Therefore, the current study aimed to investigate the WTP for the booster doses of COVID-19 vaccines and its predictors in Indonesia using an online survey distributed all over the provinces of this low-middle-income country. The WTP was evaluated using a basic dichotomous contingent valuation approach, and its associated determinants were evaluated using a linear regression model. Out of 2935 responders, 66.2% (1942/2935) were willing to pay for a booster dose of the COVID-19 vaccine. The majority of respondents (63.5%) were willing to pay within a price range of 100,000–500,000 Indonesian rupiah (IDR), i.e., USD 6.71–33.57. Being older than 40 years, having a higher educational level, having a higher income, knowing and understanding that booster doses were important, and having a vaccine status that is certified halal (permissible in Islamic law), were all associated with a higher WTP for the booster dose of COVID-19 vaccines. The study findings imply that the WTP for a booster dose of COVID-19 vaccination in Indonesia is lower compared to acceptance of vaccines provided free of charge. This WTP data can be utilized to develop a pricing scheme for the booster doses of COVID-19 vaccination in the country with potential benefits in other low-income countries. The government may be required to provide subsidies for the herd immunity vaccination process to proceed as anticipated. Furthermore, the public community must be educated on the importance of vaccination as well as the fact that the COVID-19 epidemic is far from being over.

14 September 2023 in PLOS ONE
Verified
Journal Article
Open access
PDF file
JSJohanna Beulah Sornillo
Johanna Beulah Sornillo
RDRossana Ditangco
Rossana Ditangco
AKAarti Kinikar
Aarti Kinikar
KWKetut Dewi Kumara Wati
Ketut Dewi Kumara Wati
QDQuy Tuan Du
Quy Tuan Du
OAon behalf of the TREAT Asia Pediatric HIV Observational Database of IeDEA Asia-Pacific
on behalf of the TREAT Asia Pediatric HIV Observational Database of IeDEA Asia-Pacific
Despite improvements in HIV testing and earlier antiretroviral therapy (ART) initiation in children living with HIV through the years, a considerable proportion start treatment with advanced disease. We studied characteristics of children and adolescents living with HIV and their level of immunodeficiency at ART initiation using data from a multi-country Asian cohort. We included children and adolescents who were ART-naïve and <18 years of age at ART initiation from 2011 to 2020 at 17 HIV clinics in six countries. Incidence rates of opportunistic infections (OIs) in the first two years of triple-drug ART (≥3 antiretrovirals) was also reported. Competing risk regression analysis was performed to identify factors associated with first occurrence of OI. In 2,027 children and adolescents (54% males), median age at ART initiation increased from 4.5 years in 2011–2013 to 6.7 in 2017–2020, median CD4 count doubled from 237 cells/μl to 466 cells/μl, and proportion of children who initiated ART as severely immunodeficient decreased from 70% to 45%. During follow-up, 275 (14%) children who received triple-drug ART as first treatment and had at least one clinic visit, developed at least one OI in the first two years of treatment (9.40 per 100 person-years). The incidence rate of any first OI declined from 12.52 to 7.58 per 100 person-years during 2011–2013 and 2017–2020. Lower hazard of OIs were found in those with age at first ART 2–14 years, current CD4 ≥200 cells/μl, and receiving ART between 2017 and 2020. The analysis demonstrated increasing number of children and adolescents starting ART with high CD4 count at ART start. The rate of first OI markedly decreased in children who started ART in more recent years. There remains a clear need for improvement in HIV control strategies in children, by promoting earlier diagnosis and timely treatment.

18 March 2019 in Biomedical and Pharmacology Journal
Verified
Journal Article
Open access
KWKetut Dewi Kumara Wati
Ketut Dewi Kumara Wati
EPEndah Dhyanti Pratiwi
Endah Dhyanti Pratiwi
YDYanni Dirgantara
Yanni Dirgantara
CSCynthia Retna Sartika
Cynthia Retna Sartika
MDMeita Dhamayanti
Meita Dhamayanti
IPIda Parwati
Ida Parwati
Problem in growth might need to be sought deeper inside the cells to enhance better management. There was a lack of study done in chondrocytes to determine growth problem mechanism. We sought to see the chondrocyte’s life span by observing the cells characteristic in a small container over long period. Human mesenchymal stem cell-derived MSC underwent chondrocyte differentiation procedure in a 96 wells-plate using chondrocyte/osteocyte differentiation medium followed by basal medium. A morphological observation and MTT assay was done to observe apoptosis in chondrocyte in the different wells. MTT assay absorbance was used to determine number of apoptosis. Statistical analysis was done to assess the different of mean absorbance values on different days of observation using Anova folowed by post hoc analysis in SPSS IBM package version 24 , with significance determined at P<0.05. Chondrocytes was confirmed with 1% Alcian blue staining and showed characteristic larger then its parent MSC. The MTT assay showed that chondrocyte absorbance reduce from day 3 through day 14, which was different significantly (anova, P=0.03) and day 14 was the most differed compared to day 7 and day 10 (P=0.02, P=0.017 and P=0.013, respectively). The 2D monolayer chondrocyte underwent total apoptosis on day 14 which can set the limit for observation in further long-term observational cell study.

4 September 2025 in CHILD`S HEALTH
Verified
Journal Article
Open access
CKCarlson Kurniawan
Carlson Kurniawan
IWI Gusti Ayu Trisna Windiani
I Gusti Ayu Trisna Windiani
KWKetut Dewi Kumara Wati
Ketut Dewi Kumara Wati
IKI Made Kardana
I Made Kardana
ISIda Bagus Gede Suparyatha
Ida Bagus Gede Suparyatha
MAMade Arimbawa
Made Arimbawa
Background. Systemic lupus erythematosus (SLE) is a long-term autoimmune disease that affects multiple organs, often requires prolonged treatment, and is characterized by remission and flare condition. Its chronic nature may impact children’s mental health. This study proposed to explore whether the duration of illness is linked to mental health disorders in children with SLE. Materials and methods. This cross-sectional study included 62 children aged 13–18 (median of 15) years with SLE at the Ngoerah Hospital, Bali, between January 2022 and March 2025. Mental health was assessed using the Depression, Anxiety, and Stress Scale-21 (DASS-21). Data were analyzed using chi-square for bivariate and logistic regression for multivariate to examine the association between duration of illness and mental health disorders. Other factors were also analyzed. Results. Mental health disorders were found in 32.3 % of participants. Of these, 8.1 % had depression, 4.8 % experienced anxiety, 1.6 % experienced stress, and 17.7 % experienced co-occurring symptoms of stress, and/or anxiety, and/or depression. There was no significant association between duration of illness and mental health disorders (p = 0.247). Children with active disease had a much higher risk of mental health issues (p = 0.007; odds ratio 47.3, 95% confidence interval 2.814–795.105). Conclusions. The duration of illness was not related to mental health disorders in children with SLE. In contrast, active disease was strongly associated with mental health disorders. These findings highlight the need for mental health screening in children with SLE.

5 June 2022 in Folia Medica Indonesiana
Verified
Journal Article
Open access
PDF file
PRPutu Indah Rahmawati
Putu Indah Rahmawati
ISI Nyoman Supadma
I Nyoman Supadma
KWKetut Dewi Kumara Wati
Ketut Dewi Kumara Wati
IAI Wayan Dharma Artana
I Wayan Dharma Artana
Highlights: Abstract: The cognitive, motor and language aspect of HIV-infected children is an important issue affecting their quality of life. The capute scale, divided into Cat and Clams scores, is commonly used to assess children's cognitive, motor, and language functions. This study assessed Cat and Clams’ scores of HIV-infected children. We performed Cat and Clams assessment on 136 children consisting of 68 HIV-infected children and 68 normal children as control aged 0-36 months. The Capute scale examined both groups at the first meeting (first month), and for the rest six months, we evaluated the progress of cognitive, motor, and language development. In the first meeting, we found that HIV-infected children had significantly low capute scores than the control group. The sixth-month Capute score in HIV-infected children was also significantly lower than the control group. HIV-infected children had lower Capute scores than normal children.